GIC Private Limited Form 8.3 - Allergan plc (5169M)
11 Mayo 2020 - 7:00AM
UK Regulatory
TIDMIRSH TIDM0Y7T
RNS Number : 5169M
GIC Private Limited
11 May 2020
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing GIC Private Limited
(Note 1)
Company dealt in Allergan PLC
===================
Class of relevant security Ordinary Shares
to which the dealings
being disclosed relate
(Note 2)
===================
Date of dealing 08 May 2020
===================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
============= ======== =========== ======
(1) Relevant securities
- Ordinary Shares 1,752,263 (0.5323%) -
======================= ===================
(2) Derivatives (other - -
than options)
======================= ===================
(3) Options and agreements - -
to purchase/sell
======================= ===================
Total 1,752,263 (0.5323%) -
======================= ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities - -
- Preferred Shares
=================== =====================
- -
(2) Derivatives (other
than options)
=================== =====================
- -
(3) Options and agreements
to purchase/sell
=================== =====================
Total - -
=================== =====================
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
Sale 96,800 ordinary shares USD 193.02
====================================== ====================
Sale 4,309,711 ordinary USD 192.14
shares
====================================== ====================
Sale 388 ordinary shares USD 193.07
====================================== ====================
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to
the
voting rights of any relevant securities under any option
referred to on this form or relating to
the voting rights or future acquisition
or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If
none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) YES/NO
Date of disclosure 11 May 2020
Contact name Celine Loh
==============
Telephone number (65) 6889 8952
==============
If a connected EFM, name NA
of offeree/offeror with
which connected
==============
If a connected EFM, state NA
nature of connection (Note
10)
==============
This announcement has been issued through the Companies
Announcement Service of Euronext Dublin.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISESFUFFFESSEII
(END) Dow Jones Newswires
May 11, 2020 08:00 ET (12:00 GMT)
Allergan (LSE:0Y7T)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Allergan (LSE:0Y7T)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
